Voyager Therapeutics, Inc. (VYGR) NASDAQ
3.59
-0.2(-5.28%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.59
-0.2(-5.28%)
Currency In USD
| Market Cap | 230.66M |
| Enterprise Value | 201.86M |
| P/E Ratio | -1.83 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 5.94 |
| Price/Book Ratio | 1.23 |
| Enterprise/Revenue | 5.7 |
| Enterprise/EBITDA | -1.73 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -3.2 |
| Operating Margin | -3.49 |
| Return On Assets | -0.53 |
| Return On Equity | -0.56 |
| Revenue | 40.37M |
| Revenue/Share | 0.61 |
| Gross Profit | 40.37M |
| EBITDA | -127.78M |
| Net Income | -119.72M |
| Diluted EPS | -2.04 |
| Total Cash | 141.48M |
| Total Cash/Share | 2.38 |
| Total Debt | 34.57M |
| Total Debt/Equity | 0.2 |
| Current Ratio | 8.42 |
| Book Value Per Share | 2.92 |
| 52-Week Change | 9.12 |
| 52-Week High | 5.55 |
| 52-Week Low | 2.83 |
| Moving Average 50 Days | 3.91 |
| Moving Average 200 Days | 4.09 |
| Average Volume | 681,592 |
| Shares Outstanding | 60.42M |
| % Held by Institutions | 57.11 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |